Symbol
| HDAC8
| contributors: mct/npt - updated : 08-11-2015
|
HGNC name
| histone deacetylase 8
|
HGNC id
| 13315
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in cancer tissues | constitutional
|  
|  
| --low
|  
|
caused centrosome splitting, which could also be induced by depleting a centriole-linker protein, rootletin | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | hemopathy | | |
HDAC8 inhibitors may have therapeutic potential for the treatment of myeloproliferative neoplasms (MPNs) | cancer | | | |
HDAC8-targeting agents might be explored as an adjuvant for tumors carrying a mutant TP53 |
| | | |
| deletion of Hdac8 in mice leads to perinatal lethality due to skull instability |